Examkin

Question

Difficulty: MediumBias, Confounding, and Validity

A medical investigation team is conducting a retrospective cohort study to evaluate the risk of acute kidney injury (AKI) associated with a newly introduced intravenous antimicrobial agent compared to a standard treatment regimen. The investigators suspect that pre-existing chronic kidney disease (CKD) might distort the primary association. To investigate this, they perform a stratified analysis based on baseline CKD status.

The results yield a crude relative risk (RR) of 2.8 for AKI in the new antimicrobial group. However, the stratum-specific RR for patients with baseline CKD is 1.1, and the RR for patients without baseline CKD is 1.2. The Mantel-Haenszel adjusted RR is calculated to be 1.15.

Based on these findings, which of the following statements are correct regarding the statistical interpretation and methodological handling of this variable? (Select all that apply)

  1. The data demonstrates that baseline renal status is a confounding factor rather than an effect modifier.Answer
  2. Restricting study enrollment solely to patients without pre-existing renal impairment is a valid design-phase method to prevent this specific statistical issue.Answer
  3. C
    The statistical findings suggest that the new antimicrobial agent synergistically interacts with pre-existing renal disease to increase toxicity.
  4. D
    The crude risk estimate should be reported as the primary finding because statistical adjustment artificially dilutes the true clinical effect.
  5. E
    Stratification reveals that the drug's nephrotoxic impact is significantly more pronounced in the subgroup with compromised baseline renal function.

Answer

The correct statements are that the data demonstrates confounding rather than effect modification, and that restricting study enrollment is a valid design-phase method to prevent this issue.
The scenario presents classic criteria for confounding: a significant discrepancy between the crude risk estimate and the adjusted/stratum-specific estimates, while the stratum-specific estimates remain similar to one another. Once identified as a confounder, standard epidemiological methods can be applied for control. Restricting the study to a single stratum (e.g., only enrolling patients without pre-existing renal impairment) is a highly effective design-stage method to eliminate the confounding effect of that variable.

Step-by-Step Solution

1
Analyze the relationship between the crude relative risk and the stratum-specific relative risks.
The crude RR is 2.8, while the stratum-specific RRs are 1.1 and 1.2. The adjusted RR is 1.15.
Comparing crude to stratum-specific estimates is the standard method for differentiating confounding from effect modification.
2
Determine if the variable is a confounder or an effect modifier based on the analysis.
Because the stratum-specific RRs (1.1 and 1.2) are similar to each other and to the adjusted RR (1.15), but significantly different from the crude RR (2.8), the variable is a confounder.
Confounding distorts the overall (crude) association, which is corrected upon stratification. Effect modification occurs when the magnitude of the effect differs across strata.
3
Evaluate potential methods for controlling the identified statistical issue.
Since the issue is confounding, appropriate control methods include design-phase strategies (randomization, matching, restriction) and analysis-phase strategies (stratification, multivariable regression).
Identifying the correct mitigation strategies requires matching the statistical issue (confounding) with valid epidemiological tools. Restriction (excluding CKD patients) correctly addresses confounding during the design phase.

Key Concept

Confounding vs. Effect Modification and Methods of Control
Rate this question

Topics

Bias, Confounding, and Validity

More questions from this topic